Grasemann H - Search Results

1

New Developments in Cystic Fibrosis Airway Inflammation.

Palaniyar N, Mall MA, Taube C, Worgall S, Grasemann H. Palaniyar N, et al. Among authors: grasemann h. Mediators Inflamm. 2015;2015:769425. doi: 10.1155/2015/769425. Epub 2015 Jun 29. Mediators Inflamm. 2015. PMID: 26221065 Free PMC article. No abstract available.

2

Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.

Grasemann H, Kurtz F, Ratjen F. Grasemann H, et al. Am J Respir Crit Care Med. 2006 Jul 15;174(2):208-12. doi: 10.1164/rccm.200509-1439OC. Epub 2006 Apr 20. Am J Respir Crit Care Med. 2006. PMID: 16627863

3

Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.

Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Döring G. Ratjen F, et al. Among authors: grasemann h. Pediatr Pulmonol. 2007 Mar;42(3):249-55. doi: 10.1002/ppul.20562. Pediatr Pulmonol. 2007. PMID: 17243185

4

Inhalation of Moli1901 in patients with cystic fibrosis.

Grasemann H, Stehling F, Brunar H, Widmann R, Laliberte TW, Molina L, Döring G, Ratjen F. Grasemann H, et al. Chest. 2007 May;131(5):1461-6. doi: 10.1378/chest.06-2085. Chest. 2007. PMID: 17494794 Clinical Trial.

5

SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.

Douda DN, Farmakovski N, Dell S, Grasemann H, Palaniyar N. Douda DN, et al. Among authors: grasemann h. Orphanet J Rare Dis. 2009 Dec 23;4:29. doi: 10.1186/1750-1172-4-29. Orphanet J Rare Dis. 2009. PMID: 20030831 Free PMC article.

6

Sputum induction in routine clinical care of children with cystic fibrosis.

Al-Saleh S, Dell SD, Grasemann H, Yau YC, Waters V, Martin S, Ratjen F. Al-Saleh S, et al. Among authors: grasemann h. J Pediatr. 2010 Dec;157(6):1006-1011.e1. doi: 10.1016/j.jpeds.2010.06.001. Epub 2010 Jul 14. J Pediatr. 2010. PMID: 20630539

7

Emerging therapies for cystic fibrosis lung disease.

Grasemann H, Ratjen F. Grasemann H, et al. Expert Opin Emerg Drugs. 2010 Dec;15(4):653-9. doi: 10.1517/14728214.2010.517746. Epub 2010 Sep 3. Expert Opin Emerg Drugs. 2010. PMID: 20812885 Review.

8

Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.

Grasemann H, Al-Saleh S, Scott JA, Shehnaz D, Mehl A, Amin R, Rafii M, Pencharz P, Belik J, Ratjen F. Grasemann H, et al. Am J Respir Crit Care Med. 2011 May 15;183(10):1363-8. doi: 10.1164/rccm.201012-1995OC. Epub 2011 Jan 28. Am J Respir Crit Care Med. 2011. PMID: 21278301

9

Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping.

Douda DN, Jackson R, Grasemann H, Palaniyar N. Douda DN, et al. Among authors: grasemann h. J Immunol. 2011 Aug 15;187(4):1856-65. doi: 10.4049/jimmunol.1004201. Epub 2011 Jul 1. J Immunol. 2011. PMID: 21724991

10

New therapies in cystic fibrosis.

Ratjen F, Grasemann H. Ratjen F, et al. Among authors: grasemann h. Curr Pharm Des. 2012;18(5):614-27. doi: 10.2174/138161212799315984. Curr Pharm Des. 2012. PMID: 22229570 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page